Navigation Links
Neue Studie kommt zu dem Schluss, dass manche Patienten mit Refluxkrankheit von Stretta eher profitieren als von chronischer Behandlung mit Protonenpumpenhemmern oder Antireflux-Operation
Date:9/6/2013

#246;hre, wodurch die Symptome der Refluxkrankheit gelindert werden.

„Wir haben eine großen Menge klinischer Daten untersucht, darunter kontrollierte und randomisierte Studien sowie Studien mit einer langen Nachsorgephase, und kommen zu dem Schluss, dass Stretta eine sichere, wirksame, lang anhaltende und sinnvolle Therapieoption für Patienten ist, die sich eine Linderung der Symptome ihrer Refluxkrankheit wünschen", erklärt Dr. Triadafilopoulos. „Dies ist von besonderer Bedeutung angesichts aktueller Bedenken gegenüber einer Langzeittherapie mit Protonenpumpenhemmern und für Patienten mit erfolgloser Antireflux-Operation", so Dr. Triadafilopoulos weiter.

Laut dem US-amerikanischen Gesundheitsinstitut NIH leiden ca. 20 % der amerikanischen Bevölkerung mindestens einmal pro Woche an Symptomen der Refluxkrankheit, und Ärzte suchen nach geeigneten Therapieoptionen. SAGES hat jüngst Leitlinien veröffentlicht (Surgical Endoscopy, August 2013), die der Stretta-Therapie eine GRADE-Empfehlung von „++++/strong" verleihen mit Verweis auf aussagekräftige Resultate aus 32 klinischen Studien. Kürzlich vorgestellte Beobachtungsdaten für einen Zeitraum von 10 Jahren nach Stretta-Behandlung lassen darauf schließen, dass Stretta eine wirksame Langzeittherapie für Patienten mit Refluxkrankheit ist.

Dr. Triadafilopoulos erklärt mit Verweis auf die Studiendaten, dass Stretta die längste Erfahrung aller nichtoperativen Verfahren hat. „Als Ärzte wollen wir die Lebensqualität der Patienten verbessern", so Triadafilopoulos. „Wir sind es Patienten, die an Refluxkrankheit leiden, schuldig, diese sinnvolle Therapiealternative anzubieten."

Weitere Informationen zu Stretta finden Sie unter stretta-therapy.com.

ÜBER STRETTA®

Stretta ist eine minimalinvasive Behandlung
'/>"/>

SOURCE Mederi Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Free Download: Two Impressive Case Studies on Drug Delivery Discoveries
2. National Pharmaceutical Council Studies New Formulary Decision-Making Tool
3. Start-up Seeks Crowd Funding to Complete Clinical Studies Supporting Breakthrough Blood Test for Earlier Detection of Melanoma
4. Sihuan Pharmaceutical Secures SFDA Approval for Anaprazole Sodium Category 1.1 New Drug Clinical Studies
5. Phase III studies show linagliptin improved blood glucose control in Asian adults with type 2 diabetes
6. NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinsons Disease
7. Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
8. Updated Results of Two Phase 2 Ibrutinib Studies in Patients with Mantle Cell Lymphoma or Diffuse Large B-cell Lymphoma
9. Xenon Licenses Antisense Drug XEN701 From Isis and Initiates Preclinical Toxicology Studies
10. Een studie in het New England Journal of Medicine bevestigt dat universele dekolonisatie van ic-patiënten voor 44% minder bloedstroominfecties zorgt
11. Vanda Presents Data From Tasimelteon Phase III Studies In Non-24-Hour Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... 1, 2014  ResMed (NYSE: RMD ), a ... company to design complete sleep apnea solutions specifically for women, ... importance of a good night,s sleep. The ... that feeling tired is just part of living a busy ... a critical pillar of health, essential to not only living ...
(Date:10/1/2014)... 1, 2014 Trovagene, Inc., (NASDAQ:  TROV) ... that Eli Diamond , MD, Assistant Attending ... presented clinical data from an ongoing study demonstrating ... for the determination of oncogene mutational status in ... results were presented to both treating physicians and ...
(Date:10/1/2014)... 2014  Express Scripts (NASDAQ: ESRX ) ... Scripts Medicare ® Prescription Drug Plans (PDP) will ... WAG ) (NASDAQ: WAG ), ... support  for their Medicare dollars. Medicare beneficiaries ... or Choice plans for 2015 can ...
Breaking Medicine Technology:ResMed Launches Initiative to Help Women Get Better Sleep 2ResMed Launches Initiative to Help Women Get Better Sleep 3Clinical Performance of Trovagene's Precision Cancer Monitoring Platform Presented at Second Annual International ECD Medical Symposium 2Clinical Performance of Trovagene's Precision Cancer Monitoring Platform Presented at Second Annual International ECD Medical Symposium 3Clinical Performance of Trovagene's Precision Cancer Monitoring Platform Presented at Second Annual International ECD Medical Symposium 4Express Scripts Collaborates with Walgreens to Create Value-Driven Medicare Prescription Drug Plan Pharmacy Network 2Express Scripts Collaborates with Walgreens to Create Value-Driven Medicare Prescription Drug Plan Pharmacy Network 3Express Scripts Collaborates with Walgreens to Create Value-Driven Medicare Prescription Drug Plan Pharmacy Network 4
... NEW YORK, Feb. 6, 2012 ... market research report is available ... Commercializing Angiogenesis Affecting ... Route to Consider Your Options ...
... Reportlinker.com announces that a new market research ... , World Market for Anti-Infectives (Antifungals, ... http://www.reportlinker.com/p0769020/World-Market-for-Anti-Infectives-Antifungals-Antibacterials-and-Antivirals- .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication ... World Market for Anti-Infectives - focuses ...
Cached Medicine Technology:Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others 2Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others 3Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others 4Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others 5Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others 6Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others 7Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others 8Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others 9Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others 10Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others 11Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others 12Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others 13Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others 14Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others 15Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others 16Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others 17Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others 18Commercializing Angiogenesis Affecting Drugs in Cancer: The Faster Route to Consider Your Options and Position of Others 19World Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals) 2World Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals) 3World Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals) 4World Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals) 5World Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals) 6World Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals) 7World Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals) 8World Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals) 9
(Date:10/1/2014)... research suggests the adage that encourages people to keep ... when it comes to exercise. When walking, staying focused ... to it appear shorter and help people walk there ... this technique to walking while looking around the environment ... of exercise. , "People are less interested in exercise ...
(Date:10/1/2014)... Insuranceragents.info has released a new blog ... plan for vulnerable family members. , Life insurance plans ... in the family should always carry a life insurance ... the rest of the family. , Clients can ... more from temporary coverage or from a permanent policy. ...
(Date:10/1/2014)... First Warning Systems, a pioneer in ... throughout the body, announced the company is changing its ... company’s breadth of upcoming product releases. The initial focus ... , “Our initial focus will be an ‘Internet of ... circadian cellular changes over time,” said Rob Royea, president ...
(Date:10/1/2014)... Farmington Company today announced it ... and visual identity helping brokers, consultants and companies ... to create greater benefit communication synergies. They unveiled ... empowering customers to better leverage Farmington Company’s industry-tested ... of the rebrand is the refreshed tagline: For ...
(Date:10/1/2014)... California (PRWEB) October 01, 2014 Beverly ... Dr. Kathleen Mojas is celebrating 20 years of private ... assisted hundreds of people to achieve greater joy and ... important list of warning signs and suggestions for anyone ... Dr. Mojas explains: “Believe it or not, it’s ...
Breaking Medicine News(10 mins):Health News:Keeping your eyes on the prize can help with exercise, NYU study finds 2Health News:Keeping your eyes on the prize can help with exercise, NYU study finds 3Health News:Life Insurance for Families - Clients Can Compare Affordable Rates Online! 2Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 2Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 3Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 4Health News:Farmington Company Launches Rebrand and New Positioning 2Health News:Prominent Beverly Hills Psychologist Dr. Kathleen Mojas Celebrating 20 Years in Private Practice Identifies Common Warning Signs That You May Be In a Toxic Relationship. 2Health News:Prominent Beverly Hills Psychologist Dr. Kathleen Mojas Celebrating 20 Years in Private Practice Identifies Common Warning Signs That You May Be In a Toxic Relationship. 3
... patients with cirrhosis have significant functional disability, require twice ... on the health care system, according to U-M research ... increase in obesity and aging of those with hepatitis ... climb among older Americans.. Cirrhosis is a ...
... TUESDAY, Jan. 10 (HealthDay News) -- Asian-Americans are more ... attack than whites, new research reveals, although this disparity ... quality improvement program. In the study, doctors examined ... patient was prescribed aspirin or ACE inhibitors (heart drugs) ...
... shows that older Americans with cirrhosis have significantly worse ... without this potentially deadly disease. In fact, findings now ... the American Association for the Study of Liver Diseases, ... amount of informal caregiving and contribute added strain on ...
... HealthDay Reporter , TUESDAY, Jan. 10 (HealthDay ... early clinical trial of the drug Nexavar (sorafenib) in ... in better news, an experimental drug known as ganetespib ... The results of both studies were to be presented ...
... 10, 2012. Kessler Foundation and the University of ... collaborate on clinical research projects applying virtual reality ... goal, according to USC,s Albert Rizzo, PhD of ... to conduct research to develop the evidence base ...
... Reporter , MONDAY, Jan. 9 (HealthDay News) -- For years, people ... of dying from a heart attack, stroke or cancer even if ... into question. Low-dose daily aspirin therapy does not reduce ... new study in the Jan. 9 online edition of the ...
Cached Medicine News:Health News:High rates of disability and health care use found in older Americans with cirrhosis 2Health News:Asian-Americans More Apt to Die in Hospital After Heart Attacks 2Health News:High rates of disability and health care use for older americans with cirrhosis 2Health News:Mixed News on Tough-to-Treat Lung Cancer 2Health News:Mixed News on Tough-to-Treat Lung Cancer 3Health News:Kessler Foundation and USC collaborate on clinical virtual reality for disability research 2Health News:Low-Dose Aspirin to Prevent First Heart Attack or Stroke? Not So Fast 2Health News:Low-Dose Aspirin to Prevent First Heart Attack or Stroke? Not So Fast 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: